The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The FDA classified LifeVac as a Class II medical device
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
Heart failure affects an estimated 64.3 million people worldwide
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
Subscribe To Our Newsletter & Stay Updated
